{
  "variants": [
    {
      "gene": "LRRK2",
      "protein_change": "I1915T",
      "variant_string_id": "LRRK2 I1915T",
      "acmg_flowchart": {
        "step_1": {
          "question": "Define the disease mechanism.",
          "answer": "Yes",
          "notes": "The paper explicitly states that gain-of-function mutations in LRRK2 cause Parkinson's disease via miRNA pathway disruption and E2F1/DP overproduction."
        },
        "step_2": {
          "question": "Assay applicability to disease mechanism.",
          "answer": "Yes",
          "notes": "The EGFP reporter system directly measures miRNA pathway activity, which is central to the disease mechanism."
        },
        "step_3": {
          "step_3a": {
            "question": "Basic controls and replicates.",
            "answer": "Yes",
            "notes": "Wild-type (WT) proteins and pathogenic variants (dLRRK(I1915T)) were used as controls. The text mentions 'more so than WT proteins' indicating comparative analysis."
          },
          "step_3b": {
            "question": "Variant controls (pathogenic/benign).",
            "answer": "No",
            "notes": "No explicitly listed known pathogenic/benign variants were used as controls beyond the tested variants."
          },
          "step_3c": {
            "question": "Variant controls (pathogenic/benign).",
            "answer": "No",
            "notes": "No explicit use of known pathogenic/benign variants as controls in the assay."
          }
        },
        "step_4": {
          "step_4a": {
            "question": "Statistical analyses (OddsPath).",
            "answer": "No",
            "notes": "No explicit p-values, effect sizes, or OddsPath calculations are reported."
          },
          "step_4b": {
            "question": "Number of variant controls.",
            "answer": "Max PS3_supporting",
            "notes": "Fewer than 10 total variant controls (e.g., dLRRK(I1915T), hLRRK2(G2019S), and genetic deletions) were used."
          }
        }
      },
      "evidence_strength": "PS3_supporting"
    },
    {
      "gene": "LRRK2",
      "protein_change": "G2019S",
      "variant_string_id": "LRRK2 G2019S",
      "acmg_flowchart": {
        "step_1": {
          "question": "Define the disease mechanism.",
          "answer": "Yes",
          "notes": "The paper explicitly states that gain-of-function mutations in LRRK2 cause Parkinson's disease via miRNA pathway disruption and E2F1/DP overproduction."
        },
        "step_2": {
          "question": "Assay applicability to disease mechanism.",
          "answer": "Yes",
          "notes": "The EGFP reporter system directly measures miRNA pathway activity, which is central to the disease mechanism."
        },
        "step_3": {
          "step_3a": {
            "question": "Basic controls and replicates.",
            "answer": "Yes",
            "notes": "Wild-type (WT) proteins and pathogenic variants (hLRRK2(G2019S)) were used as controls. The text mentions 'more so than WT proteins' indicating comparative analysis."
          },
          "step_3b": {
            "question": "Variant controls (pathogenic/benign).",
            "answer": "No",
            "notes": "No explicitly listed known pathogenic/benign variants were used as controls beyond the tested variants."
          },
          "step_3c": {
            "question": "Variant controls (pathogenic/benign).",
            "answer": "No",
            "notes": "No explicit use of known pathogenic/benign variants as controls in the assay."
          }
        },
        "step_4": {
          "step_4a": {
            "question": "Statistical analyses (OddsPath).",
            "answer": "No",
            "notes": "No explicit p-values, effect sizes, or OddsPath calculations are reported."
          },
          "step_4b": {
            "question": "Number of variant controls.",
            "answer": "Max PS3_supporting",
            "notes": "Fewer than 10 total variant controls (e.g., dLRRK(I1915T), hLRRK2(G2019S), and genetic deletions) were used."
          }
        }
      },
      "evidence_strength": "PS3_supporting"
    }
  ]
}